BRAȘOV, Romania – A 5,000-year-old antibiotic-resistant bacterium, recently exhumed from a Romanian cave, has reportedly retained legal counsel and is demanding royalties for its 'intellectual property' and 'cultural impact.' The ancient microorganism, tentatively named *Bacillus Transylvanius Rex*, claims its millennia-long resistance to modern medicine constitutes a pre-existing condition that should be compensated.

Dr. Arpad Kovács, Head of Palaeo-Microbial Jurisprudence at the University of Cluj-Napoca, stated, 'This is unprecedented. The bacterium's legal team, a consortium of highly aggressive amoebas, argues that its genetic blueprint for resistance predates all known pharmaceutical patents by several millennia. They're seeking back pay, future licensing fees, and a percentage of all global antibiotic sales.'

Sources close to the bacterium, who wish to remain anonymous for fear of cellular litigation, indicate that *B. Transylvanius Rex* is also in advanced talks for a multi-platform media deal, including a documentary series and a line of 'vintage pathogen' merchandise. 'It's a shrewd operator,' noted Ms. Elara Vance, a fictional expert in 'Pathogen-Celebrity Relations' from the Institute for Interspecies Negotiations. 'It understands its brand. We're even hearing whispers of a potential cameo in the next *Underworld* film, provided its rider for optimal humidity and nutrient broth is met.'

The bacterium's demands have sent shockwaves through the scientific and legal communities, with many fearing a precedent that could empower other ancient pathogens to emerge from dormancy and stake their own claims on human innovation.